Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India

Open Access

Peer-reviewed

Research Article

Kristen M. Little ,

* E-mail: klittl11@jhu.edu

Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯
Madhukar Pai,

Affiliation Department of Epidemiology, Biostatistics, and Occupational Health, McGill University and McGill International TB Centre, Montreal, Canada
⨯
David W. Dowdy

Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯

Reader Comments (0)

Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Tuberculosis diagnosis and management
Is the Subject Area "Tuberculosis diagnosis and management" applicable to this article?

Thanks for your feedback.
Multi-drug-resistant tuberculosis
Is the Subject Area "Multi-drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
India
Is the Subject Area "India" applicable to this article?

Thanks for your feedback.
Sputum
Is the Subject Area "Sputum" applicable to this article?

Thanks for your feedback.
Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.
HIV diagnosis and management
Is the Subject Area "HIV diagnosis and management" applicable to this article?

Thanks for your feedback.